Enhancing Therapy Adherence Among Metastatic Breast Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

May 3, 2023

Primary Completion Date

February 15, 2024

Study Completion Date

May 15, 2024

Conditions
Metastatic Breast Cancer
Interventions
DEVICE

Decision Support System

"TREAT (TREatment Adherence SupporT) is a web-based DSS that comprises four sections:~i) Metastatic Breast Cancer: contains information about MBC and its physical and psychological consequences;~ii) Adherence to Cancer Therapies: contains information about adherence in the cancer population;~iii) Promoting Adherence: contains information about resources, barriers, and available interventions used to foster adherence;~iv) My Adherence Diary."

Trial Locations (1)

20141

European Institute fo Oncology, Milan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

European Institute of Oncology

OTHER

NCT06161181 - Enhancing Therapy Adherence Among Metastatic Breast Cancer Patients | Biotech Hunter | Biotech Hunter